The soluble guanylate cyclase activator BAY 58-2667 protects against morbidity and mortality in endotoxic shock by recoupling organ systems

Benzer Materyaller

• The Soluble Guanylate Cyclase Activator BAY 58-2667 Protects against Morbidity and Mortality in Endotoxic Shock by Recoupling Organ Systems
  Yazar:: Vandendriessche, Benjamin, ve diğerleri
  Baskı/Yayın Bilgisi: (2013)
• Pharmacological preconditioning with the guanylate cyclase activator cinaciguat (BAY 58-2667) protects against reperfusion injury after cardiopulmonary bypass
  Yazar:: Radovits, Tamás, ve diğerleri
  Baskı/Yayın Bilgisi: (2009)
• Antiplatelet effects of aspirin are not affected by the soluble guanylate cyclase activator cinaciguat (BAY 58-2667)
  Yazar:: Frey, Reiner, ve diğerleri
  Baskı/Yayın Bilgisi: (2011)
• Relaxant effect of BAY 41-2272 and BAY 58-2667 in the gastrointestinal tract of apo-sGC mice
  Yazar:: Cosyns, Sarah, ve diğerleri
  Baskı/Yayın Bilgisi: (2011)
• The Soluble Guanylyl Cyclase Activator Bay 58-2667 Selectively Limits Cardiomyocyte Hypertrophy
  Yazar:: Irvine, Jennifer C., ve diğerleri
  Baskı/Yayın Bilgisi: (2012)